홈 › 루푸스 › 텍사스

텍사스의 루푸스 임상 시험

루푸스 관련 연구 26개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Novel Research LLC, Bellaire
Accurate Clinical Research, League City
Epic Medical Research, Red Oak

피험자 모집 중3상

12세 ~ 100세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06133972

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Prolato Clinical Research Center, Houston

피험자 모집 중2상

18세 ~ 100세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05268289

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Amarillo Center for Clinical Research, Amarillo
Precision Comprehensive Clinical Research Solutions - Colleyville, Colleyville
Precision Comprehensive Clinical Research Solutions, Euless
외 4개

피험자 모집 중2상

18세 ~ 74세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07409181

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Research Site, El Paso
Research Site, Houston

피험자 모집 중3상

5세 ~ 17세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05835310

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Austin
Research Site, Baytown
Research Site, Colleyville
외 3개

피험자 모집 중3상

18세 ~ 70세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07430306

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Amarillo Medical Specialists Rheumatology, Amarillo
Amarillo Center for Clinical Research, Amarillo
Arthritis and Rheumatology Research Institute, Frisco
외 5개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Epic Medical Research /ID# 279180, Red Oak

피험자 모집 중1상

18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07607964

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
외 2개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03816345

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Allen
Research Site, Mesquite

피험자 모집 중1상

18세 ~ 65세 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07201558

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

North Texas Center for Clinical Research, Frisco
Accurate Clinical Research, Humble

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07355218

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Baylor College of Medicine, Houston

피험자 모집 중1상

18세 ~ 60세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06975787

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

The University of Texas Southwestern Medical Center, Dallas

피험자 모집 중2상

12세 ~ 70세 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Allen Arthritis, Allen
Arthritis and Rheumatology Research Institute PLLC, Allen
Arthritis Care of Texas, Corpus Christi

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07332481

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50738, Bellaire
Sl0044 50781, El Paso
Sl0044 50673, Fort Worth
외 7개

피험자 모집 중3상

16세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06617325

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Arthritis Care of Texas - Corpus Christi, Corpus Christi
Lone Star Arthritis & Rheumatology Associates, P.C., Denton
El Paso Medical Research Institute (MedResearch, Inc), El Paso
외 1개

피험자 모집 중관찰 연구

16세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07175285

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 ~ 65세 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT06121297

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Texas Transplant Institute, San Antonio

피험자 모집 중2상

12세 ~ 65세 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT07053800

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Integrative Rheumatology of South Texas - Harlingen /ID# 276458, Harlingen

피험자 모집 중1상

18세 ~ 75세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06977724

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Rheumatology Care Center, PLLC, Bellaire
Texas Arthritis Center, El Paso
Novel Research, LLC., Houston
외 3개

피험자 모집 중3상

18세 ~ 75세 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT07201129

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Investigative Site, Allen
Investigative Site, Arlington
Investigative Site, Colleyville

피험자 모집 중2상

18세 ~ 80세 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT07260877

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Stryde Research, Plano
Tranquil Clinical Research, Webster

피험자 모집 중1상

18세 ~ 70세 · 모든 성별 · 2026. 6. 5. 업데이트됨 · NCT06613360

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US04-0, Irving
US02-0, San Antonio

피험자 모집 중1/2상건강한 지원자 환영

18세 ~ 70세 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT06625671

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 5. 20. 업데이트됨 · NCT04751396

Lupus Landmark Study: A Prospective Registry and Biorepository

UT Southwestern Medical Center, Dallas

피험자 모집 중관찰 연구

18세 ~ 110세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT05934149

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT06434363

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Climb Bio Investigative Site #100104, Allen
Climb Bio Investigative Site #100101, San Antonio

피험자 모집 중1상

18세 ~ 65세 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT07011043

ClinicalTrials.gov 출처, 2026. 10. 2. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.